5 Cancer Types With the Poorest Long-Term Outlook
There's arguably no scarier diagnosis a patient can receive from their doctor than cancer. But the grim reality, based on data from the National Cancer Institute's Surveillance, Epidemiology, and End Results program, is that 38.5% of all people, men and women, will be diagnosed with cancer at some point during their lifetime.
This year alone, the American Cancer Society (ACS) is projecting 1.69 million Americans will be diagnosed with cancer, and that nearly 601,000 people will die as a direct result of cancer. That makes it the No. 2 killer in the U.S., trailing only heart disease. However, with heart disease drugs improving and eating habits getting potentially healthier, cancer is expected to surpass heart disease and become the nation's leading killer by the next decade.
Image source: Getty Images.
Source: Fool.com
Bristol-Myers Squibb Aktie
Die Community zeigt leichtes Interesse an Bristol-Myers Squibb mit mehr Buy- als Sell-Einschätzungen.
Das Kursziel von 65 € für Bristol-Myers Squibb impliziert eine deutliche Steigerung um über 20% gegenüber 43.94 €.
